Saratov JOURNAL of Medical and Scientific Research

Biomarkers content in blood serum of patients with osseous neoformations

Year: 2016, volume 12 Issue: №3 Pages: 358-361
Heading: Clinical Laboratory Diagnostics Article type: Original article
Authors: Korshunov G.V., Pavlenko А.А., Puchinyan D.M., Shakhmartova S.G.

The aim of the study was the estimation of several biomarkers in differentiation diagnostics of tumour diseases in osseous system. Material and methods. 160 patients with benign (115) and malignant (45) osseous neoformations were investigated. Neopterine, tumour necrosis factor (TNF-а), interleukin-6, adhesion molecules of vessel endothe-lium (sVCAM-1) and vascular endothelial growth factor (VEGF) levels were identified by ELISA solid-phase test and compared with the levels of 20 apparently healthy individuals. Tumor verification was fulfilled by X-ray, CT, MRI and histomorphological essay. Results. Both benign and malignant osseous tumour patients showed increased levels of neopterine, TNF-а and interleukin-6 being more significant with malignant processes. The level of sVCAM was decreased in patients of both groups and VEGF level corresponded to the control, these indexes did not show any differences between the groups. The assessment of diagnostic value of these cytokines indicates that positive results for TNF and neopterine give the ground for the final diagnostic decision while the same results for interleukin-6 give moderate basement for diagnostic decision. Conclusion. Increased TNF-а and neopterine levels allow substantiating the difference between benign and malignant osseous tumours and improving diagnostic quality.

1. Bulychyova I.V., Solov'yov Yu.N., Kushlinsky N.E. Molecular markers in osseous tumours diagnostics. Bone and soft tissue sarcomas, skin tumours 2013; 5 (3): 73-78
2. Nikolaenko A.N. Differential diagnostics of bone tumours: PhD abstract. Moscow, 2014; 24 p.
3. Kuznik B.l. Cellular and molecular mechanisms of hemostasis system regulation in pathology and norm. Chita: Ekspress-izdatel'stvo, 2010; 828 p.
4. Tarasova Т.А. lnterlekin-6 and its receptor in blood serum of osseous tumour and tumour-like lesions: PhD abstract. Moscow, 2010; 29 p.
5. Aydin Y, Kaplan I, Bilen Y, et al. Plasma levels of IL-6 and TNF-a in patients with esophageal cancer. Turk J Med Sci 2012; 42 (5): 762-767
6. Men'shikov V.V., Pervushin Yu.V. Quality assurance and control in clinical laboratory essays. In: Russian Clinical Laboratory Diagnostics: National guidance in 2 vol. Moscow: GEOTAR-Media, 2012; vol. 1, p. 64-66
7. Pavlenko N.N., Korshunov G.V., Popova T.N., et al. Metastatic lesions of bone tissue. Siberian Journal of Oncology 2011; 10 (4): 46-49
8. Korshunov G.V., Pavlenko N.N., Puchin'yan D.M., et al. Surgical characteristics of differential diagnostics methods in benign and malignant osseous neoformations. Russian Clinical Laboratory Diagnostics 2014; 59 (6): 11-13
10. Chekhonin V.P., Shein S.A., Korchagina A.A., Gurina O.l. VEGF role in neoplastic angiogenesis development. Vestnik of the Russian Academy of Medical Sciences 2012; 67 (2): 23-33
11. Babkina I.V., Russo E.Yu., Solovyov Yu.N., etal. The content of sVCAM-1 in blood serum of osseous neoformation patients. Bone and soft tissue sarcomas, skin tumours 2012; 4 (1): 52-54.

2016_03_358-361.pdf249.81 KB

No votes yet